Syringes (Russian market)

Syringes (Global Market)

Main Article: Syringes (Global Market)

Injection Needles (Russian Market)

Main article: Injection needles (Russian market)

Needles

The photo below shows why one needle cannot be used multiple times.

2019

And this is not to mention the various possibilities of infection due to errors in sterilization.

Comparison of medical needle tip (A) with B=viper tusk, C=spider chelicera, D=scorpion stinger

2024: A plant for the production of disposable syringes-pressure gauges and polymer devices for catheter installation was launched in the Tyumen region for ₽269 million

On November 21, 2024, it became known that the production complex for the production of high-tech medical devices began work in the village of Malkovo, Tyumen region. ₽269 million investments were allocated for the construction and equipment of the building with an area of ​ ​ 4.5 thousand square meters. We are talking about the project of the Tyumen factory of medical devices ("MIM"). Read more here.

2023

Medical syringe market growth by 13% to RUB 91.21 per capita

In 2023, the volume of consumption of medical syringes per capita in Russia amounted to 91.21 rubles in monetary terms. This is 13% more compared to 2022, when the figure was 80.74 rubles. Such data are reflected in the review of the analytical agency "GuideMarket," published on November 12, 2024.

The study says that the consumption of syringes in 2015 was recorded at 40.08 rubles per person. After that, the industry showed steady positive dynamics, with the exception of 2017, when there was a fall of 8.5% on an annualized basis. This was due to a decrease in import and production volumes, as well as a decrease in the cost of imports and an increase in producer prices.

It is said that the medical syringe market in Russia is in the stage of active development. Consumer preferences are changing dynamically under the influence of price factors, production and import volumes, as well as new technological and environmental trends. The formed geopolitical situation and the imposition of sanctions against the Russian Federation did not affect the volume of imports, since the bulk of products are purchased in China. In addition, many European suppliers continued to work in the Russian market. According to analysts at GuideMarket, a relatively small number of manufacturers of medical syringes operate in the Russian Federation - about 18-20 companies. At the same time, the Central and Volga Federal Districts are in the lead in terms of production.

In general, over the period from 2015 to 2023, the consumption of medical syringes per capita in Russia increased 2.3 times. The average annual increase, taking into account the decline in 2017, is 16.3%. The increase is due to an increase in prices associated with an increase in the cost of raw materials for the production of products, as well as an increase in the cost of imported products.^[1]

Moscow Region company invests 250 million rubles in the production of angiographic syringes

On June 13, 2023, it became known about a loan of 196 million rubles, which was provided by the Industrial Development Fund (FRP) of TPK RadiusMed to launch the production of angiographic syringes in the Dubna special economic zone. Total investments in the project will exceed 250 million rubles. Read more here.

2022: Syringe production in Russia reaches 997 million units

In 2022, about 1 billion medical syringes were produced in Russia, which approximately corresponds to the indicator for 2021. Against the background of the deteriorating geopolitical situation and sanctions, domestic companies were unable to increase their output. This is stated in the review of BusinesStat, presented at the end of December 2023.

According to estimates, in 2018, about 814.5 million medical syringes were manufactured in the Russian Federation. A year later, output climbed 14.6%, reaching 933.6 million units. However, in 2020, the growth rate slowed down to 2.2% with a final result of 954 million units. Despite the increased demand for consumable medical devices during the COVID-19 pandemic, domestic manufacturers were unable to significantly increase the production of syringes. The reason was interruptions in the supply of the main types of raw materials - low-pressure polyethylene and polypropylene. Moreover, according to experts, from June 2020 to April 2021, the price of polymers doubled.

In 2021, the production of medical syringes increased by 4.9% - to 1 billion units. Production growth was supported by the commissioning of new facilities. In particular, in February 2021, Pascal Medical attracted a preferential loan from the FRP for 150 million rubles: the funds were used to expand the production of disposable syringes and needles. Mass free vaccination against coronavirus also contributed to the expansion of the market.

In 2022, the production of medical syringes in Russia decreased on an annualized basis by 0.4% - to 996.5 million units. Among the leading enterprises in the industry are named "Medical Production Company" Yelets, "" Pascal Medical, "" STK Group, "" Sterin, "" MIM, "" Medprom Bobeni Production, "" Ural Medical Company, "" Medpolymer LTD, "" AERS-Med "and"^[2]syringes^[3].

2017: Investments 600 million rubles from the Kirov plant

In August 2017, it became known about the plans of the Kirov Vostok plant to invest 600 million rubles in the production of needles for medical syringes. It will not be easy for companies to compete with foreign suppliers.

The large-scale plans of Vostok LLC were announced at the signing of a cooperation agreement with the Acting Governor of the Kirov Region Igor Vasiliev. In the document, a copy of which is at the disposal of Kommersant, Vostok is going to invest 600 million rubles in the production of disposable injection needles in 2018-2023 (of which 300 million are borrowed funds). It is assumed that the volume of shipment by 2023 will reach 200 million rubles a year. 

Kirov plant is ready to invest 600 million rubles in the production of needles for medical syringes

According to analysts cited by the publication, taking into account the import substitution policy, Kirov syringes will be in demand, but Vostok will not be easy to compete with foreign suppliers that control most of the Russian market.

It will not be possible to completely get away from imports with the opening of Kirov production, believes Nikolai Bespalov, Development Director of RNC Pharma: in addition to the Vostok imported equipment, most likely, special metal, rubber and plastic for needles will have to be purchased abroad.

This project can rather be called image. From the point of view of competitiveness, it would be advisable for an enterprise to try to attract a large foreign manufacturer as a partner, whose brand will allow promoting products, the expert believes.[4]

2016: Foreign Player Leadership

According to RNC Pharma analysts, in 2016 foreign syringes worth 4.2 billion rubles were imported into Russia (-0.2% compared to 2015), while in natural volumes supplies increased by 7% and reached 1.8 billion packages of syringes. 54% of the cash volume of products falls on Germany, in second place China (31%), the total supply of disposable syringes was carried out from 11 countries. Among the largest importers, analysts call SFM Hospital products (occupies 23.2% of the total import volume), B.Braun (13.4%) and Tianjin Medical medical equipment (11%), a total of 36 companies import syringes into Russia.

Notes